Tolerability and Clinical Activity of Post-Transplantation Azacitidine in Patients Allografted for Acute Myeloid Leukemia Treated on the RICAZA Trial

Disease relapse is the major causes of treatment failure after allogeneic stem cell transplantation (SCT) in patients with acute myeloid leukemia (AML). As well as demonstrating significant clinical activity in AML, azacitidine (AZA) upregulates putative tumor antigens, inducing a CD8(+) T cell resp...

全面介紹

Na minha lista:
書目詳細資料
發表在:Biol Blood Marrow Transplant
Main Authors: Craddock, Charles, Jilani, Nadira, Siddique, Shamyla, Yap, Christina, Khan, Josephine, Nagra, Sandeep, Ward, Janice, Ferguson, Paul, Hazlewood, Peter, Buka, Richard, Vyas, Paresh, Goodyear, Oliver, Tholouli, Eleni, Crawley, Charles, Russell, Nigel, Byrne, Jenny, Malladi, Ram, Snowden, John, Dennis, Mike
格式: Artigo
語言:Inglês
出版: Carden Jennings Publishing 2016
主題:
Brief Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4728172/
https://ncbi.nlm.nih.gov/pubmed/26363443
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2015.09.004
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍